SCHEMBL1925403

SCHEMBL1925403

COC(=O)c1cccc(CCC(C)C)c1

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 3/20 0.69
CYP4A11 Q02928 3/20 0.69
LOXL2 Q9Y4K0 1/20 0.62
SLC7A5 Q01650 1/20 0.57
FOLH1 Q04609 1/20 0.53
MRGPRX4 Q96LA9 2/20 0.50
ALDH1A1 P00352 2/20 0.50
HPGD P15428 1/20 0.50
KDM4E B2RXH2 1/20 0.49
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
HIF1A Q16665 1/20 0.48
PARP1 P09874 1/20 0.47
F2 P00734 1/20 0.47
F10 P00742 1/20 0.47
MAP1LC3B Q9GZQ8 1/20 0.46
MAP1LC3A Q9H492 1/20 0.46
CASR P41180 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL70173 0.87 CYP4F2 (0.83) CYP4F2CYP4A11LOXL2SLC7A5FOLH1
SCHEMBL9368512 0.86 MRGPRX4 (0.65) CYP4F2CYP4A11LOXL2MRGPRX4ALDH1A1
SCHEMBL27595412 0.85 CYP4F2 (0.66) CYP4F2CYP4A11LOXL2SLC7A5FOLH1
SCHEMBL1790854 0.84 SLC7A5 (0.68) CYP4F2CYP4A11LOXL2SLC7A5FOLH1
SCHEMBL27955126 0.82 SLC7A5 (0.75) CYP4F2CYP4A11LOXL2SLC7A5FOLH1
SCHEMBL27955127 0.82 SLC7A5 (0.75) CYP4F2CYP4A11LOXL2SLC7A5FOLH1
SCHEMBL13126937 0.82 MAP1LC3B (0.47) CYP4F2CYP4A11MRGPRX4HPGDMAP1LC3B
SCHEMBL46931 0.82 CYP4A11 (1.00) CYP4F2CYP4A11LOXL2SLC7A5FOLH1
SCHEMBL10609527 0.82 CYP4F2 (0.76) CYP4F2CYP4A11LOXL2SLC7A5FOLH1
SCHEMBL848969 0.82 FOLH1 (0.56) FOLH1MRGPRX4KDM4EMAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1763509-B1 ALPHA-HELICAL MIMETICS WALTER & ELIZA HALL INST MEDICAL RES (AU) 2018-02-21 EP disclosed
US-7956216-B2 Benzoyl urea derivatives mimicing BH3-only proteins, able to interact with a Bcl-2 protein THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2011-06-07 US disclosed
US-20080153802-A1 Alpha-helical mimetics THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2008-06-26 US disclosed
EP-1763509-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2007-03-21 EP disclosed
WO-2006002474-A1 ALPHA-HELICAL MIMETICS THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080153802-A1 Alpha-helical mimetics BID, BAX, BAD CYP4F2 4708/4885CYP4A11 4842/4885LOXL2 3404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.